about
Augmenting the Efficacy of Immunotoxins and Other Targeted Protein Toxins by Endosomal Escape EnhancersTargeting caspases in cancer therapeuticsAn Ecological Framework of the Human Virome Provides Classification of Current Knowledge and Identifies Areas of Forthcoming DiscoveryModeling of molecular interaction between apoptin, BCR-Abl and CrkL--an alternative approach to conventional rational drug designCreation of an apoptin-derived peptide that interacts with SH3 domains and inhibits glioma cell migration and invasion.A novel BCR-ABL1 fusion gene identified by next-generation sequencing in chronic myeloid leukemia.Mapping of apoptin-interaction with BCR-ABL1, and development of apoptin-based targeted therapy.HAMLET: functional properties and therapeutic potential.Potent anti-tumor effects of a dual specific oncolytic adenovirus expressing apoptin in vitro and in vivoNew biomarkers probing depth of cell senescence assessed by laser scanning cytometry.A novel anti-CD22 scFv-apoptin fusion protein induces apoptosis in malignant B-cells.Discovery of a genome of a distant relative of chicken anemia virus reveals a new member of the genus Gyrovirus.Efficient production of an engineered apoptin from chicken anemia virus in a recombinant E. coli for tumor therapeutic applicationsNew progress of non-surgical treatments for hepatocellular carcinoma.Antitumor effects of a dual cancer-specific oncolytic adenovirus on colorectal cancer in vitro and in vivoApoptin enhances the oncolytic properties of vaccinia virus and modifies mechanisms of tumor regression.Gallus Heat shock cognate protein 70, a novel binding partner of ApoptinEnhanced tumour cell nuclear targeting in a tumour progression model.Human gyrovirus DNA in human blood, Italy.Combination of VP3 and CD147-knockdown enhance apoptosis and tumor growth delay index in colorectal tumor allograftNonviral gene therapy in vivo with PAM-RG4/apoptin as a potential brain tumor therapeuticTherapeutic anti-tumor effect of exogenous apoptin driven by human survivin gene promoter in a lentiviral construct.Activation of the Chicken Anemia Virus Apoptin Protein by Chk1/2 Phosphorylation Is Required for Apoptotic Activity and Efficient Viral ReplicationThe chimeric multi-domain proteins mediating specific DNA transfer for hepatocellular carcinoma treatment.Human serum albumin-mediated apoptin delivery suppresses breast cancer cell growth in vitro and in vivoOncolytic viruses & their specific targeting to tumour cells.Autophagy, apoptosis, mitoptosis and necrosis: interdependence between those pathways and effects on cancer.The therapeutic effect of death: Newcastle disease virus and its antitumor potential.Selective apoptosis induction in MCF-7 cell line by truncated minimal functional region of Apoptin.Apoptin selectively induces the apoptosis of tumor cells by suppressing the transcription of HSP70.Apoptin enhances the oncolytic properties of Newcastle disease virus.Recombinant Vaccinia Viruses Coding Transgenes of Apoptosis-Inducing Proteins Enhance Apoptosis But Not Immunogenicity of Infected Tumor Cells.The efficacy of combination therapy using adeno-associated virus-mediated co-expression of apoptin and interleukin-24 on hepatocellular carcinoma.Identification of the first human gyrovirus, a virus related to chicken anemia virus.Intrinsic disorder and oligomerization of the hepatitis delta virus antigenVP2 of Chicken Anaemia Virus Interacts with Apoptin for Down-regulation of Apoptosis through De-phosphorylated Threonine 108 on Apoptin.Apoptin induces apoptosis in nude mice allograft model of human bladder cancer by altering multiple bladder tumor-associated gene expression profiles.
P2860
Q26744722-10E86ADC-F8AE-45CF-B3CF-7AB376AF9312Q26821986-FE665407-141D-4F7D-975B-58665E55F308Q27468626-30C11D61-9A2E-4ED5-BD4A-DA02A58EBBD8Q28478748-74B549DC-8712-4200-A36F-D976A8DB659FQ30008857-D00F6B08-D0BF-4E3C-9EBE-0F0370968829Q30008897-9980659E-0F4E-4A87-BF4C-E0AD40BB6639Q30009317-F209B28F-353F-49C2-8CF4-73D0F34FAFA3Q30576410-9C79994D-8BFA-4E5F-9E2A-9AF7112B7920Q33638956-3AFD4541-C6BC-4CE1-8E10-9488D54490D5Q33715537-817F1DFC-B0FD-4112-B97E-33DC22CAACB7Q33758660-A98BBD51-1FCD-4C09-89BF-3EAB18EC4699Q33856900-8051C949-2D18-4227-B10C-6B380DF534AAQ34294245-C0A89C08-2B8A-440E-AD0E-66D1B36634AEQ34647076-857300EE-10A4-42B3-B0E8-F1DA146D066DQ34795642-BDB85B37-6B8E-432C-8985-141775B44862Q34956920-ABA7614E-E448-4D99-8912-6909808F8A00Q35111448-04EB0DA0-B875-4B50-A79B-EBA807B5D557Q35127787-D38D241D-53AA-41C4-AAFD-29F3FE047757Q35980004-FD4D001A-ABD9-4342-ABE1-4ADC35F95D17Q36076605-6C6B5296-7F6D-480E-AED1-AD9D7C944E22Q36755625-733A9415-1091-42E9-96C5-C4117CED6E81Q36984046-140A0DD2-6510-45BA-BE5F-F593ADA87046Q37300406-7CCBC327-56CB-4491-93CD-86626AD1C9AEQ37336693-54F760B9-BD2C-4A4C-9D96-E1D5E0A97AA7Q37701064-B2A0132F-ABBA-4DC5-8BDF-9489FF11C418Q38061306-A4C63796-76C7-4781-8DBD-C4CE8C6100C2Q38066407-8D15B993-DB24-4902-8E1A-A93A34C8AD04Q38556725-FA601EB5-7E3E-46E2-9DDE-BE7B327C50F7Q39075960-6529D65C-B4F0-4D6A-BC3A-02D48B6D87CBQ39239188-30ACEDBF-2CCE-4E81-ACCD-9A81BCA1D1C5Q39484906-D3A12D2E-A963-4BEA-8260-03848B7C579EQ41688010-A70A5AC0-B831-40B4-8B47-A824E3A191AFQ42279694-0057BBD7-0069-42B8-9CF0-1BFD4117D9B1Q42603336-5AE21505-A003-4356-8084-EF53972FF73EQ42640572-03C01722-0736-4F47-AA5F-B2D105CF23B2Q45325403-1D262901-C144-4E31-B0CC-5921B5E0F3E4Q54271132-832FDDF5-41CD-499D-8B16-29CA1A2C7FE8
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 April 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Apoptin, a tumor-selective killer.
@en
Apoptin, a tumor-selective killer.
@nl
type
label
Apoptin, a tumor-selective killer.
@en
Apoptin, a tumor-selective killer.
@nl
prefLabel
Apoptin, a tumor-selective killer.
@en
Apoptin, a tumor-selective killer.
@nl
P2093
P1476
Apoptin, a tumor-selective killer
@en
P2093
Frank Essmann
Iran Rashedi
Klaus Schulze-Osthoff
Sanat Mandal
Soumya Panigrahi
P304
P356
10.1016/J.BBAMCR.2009.04.002
P407
P577
2009-04-15T00:00:00Z